Search Results - "CULL, Vanessa S"

Type I interferon gene therapy protects against cytomegalovirus‐induced myocarditis by Cull, Vanessa S., Bartlett, Emmalene J., James, Cassandra M.

“…Summary Type I interferons (IFNs) are produced early in response to viral infection and modulate adaptive immunity. Previously we demonstrated localized…”
Get full text

Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection by Bartlett, Emmalene J, Cull, Vanessa S, Brekalo, Natalie L, Lenzo, Jason C, James, Cassandra M

“…Delivery of type I IFN transgenes by naked DNA immunization can protect against cytomegalovirus infection and myocarditis. Here, we investigate IFN transgene…”
Get full text

Type I interferon differential therapy for erythroleukemia: specificity of STAT activation by Cull, Vanessa S., Tilbrook, Peta A., Bartlett, Emmalene J., Brekalo, Natalie L., James, Cassandra

“…Type I interferons (IFNs), pleiotropic cytokines with antiviral, antiproliferative, apoptotic, and immunoregulatory functions, are efficacious in the treatment…”
Get full text

Optimization of Naked DNA Delivery for Interferon Subtype Immunotherapy in Cytomegalovirus Infection by Bartlett, Emmalene J., Cull, Vanessa S., Mowe, Eva N., Mansfield, Josephine P., James, Cassandra M.

“…Type I interferon (IFN) gene therapy modulates the immune response leading to inflammatory heart disease following cytomegalovirus (CMV) infection in a murine…”
Get full text

Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn by TILBROOK, Peta A, PALMER, Gene A, SCHNEIDER-MERGENER, Jens, KRYSTAL, Gerald, KLINKEN, S. Peter, BITTORF, Thomas, MCCARTHY, David J, WRIGHT, Michael J, SARNA, Mohinder K, LINNEKIN, Diana, CULL, Vanessa S, WILLIAMS, James H, INGLEY, Evan

“…This study examined the impact of the tyrosine kinase Lyn on erythropoietin-induced intracellular signaling in erythroid cells. In J2E erythroleukemic cells,…”
Get full text

Type I IFN‐β gene therapy suppresses cardiac CD8+ T‐cell infiltration during autoimmune myocarditis by Bartlett, Emmalene J, Lenzo, Jason C, Sivamoorthy, Soruba, Mansfield, Josephine P, Cull, Vanessa S, James, Cassandra M

“…Gene therapy using DNA encoding type I IFN subtypes IFNA6, IFNA9 and IFNB suppresses murine cytomegalovirus (MCMV)‐myocarditis, a predominantly cell‐mediated…”
Get full text

Differential regulation of SOCS genes in normal and transformed erythroid cells by SARNA, Mohinder K, INGLEY, Evan, ALEXANDER, Warren S, HILTON, Douglas J, STARRY, Robyn, WATOWICH, Stephanie S, BITTORF, Thomas, KLINKEN, S. Peter, TILBROOK, Peta A, BUSFIELD, Samantha J, CULL, Vanessa S, LEPERE, Winald, MCCARTHY, David J, WRIGHT, Michael J, PALMER, Gene A, CHAPPELL, David, SAYER, Melissa S

“…The SOCS family of genes are negative regulators of cytokine signalling with SOCS-1 displaying tumor suppressor activity. SOCS-1, CIS and SOCS-3 have been…”
Get full text

Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-α therapy by Lenzo, Jason C., Mansfield, Josephine P., Sivamoorthy, Soruba, Cull, Vanessa S., James, Cassandra M.

“…Cytomegalovirus-induced myocarditis is largely immune-mediated. BALB/c mice produced higher levels of IL-4 in the heart indicative of a Th2-like response…”
Get full text

Interferon subtype gene therapy for regulating cytomegalovirus disease by James, Cassandra M, Bartlett, Emmalene J, Mansfield, Josephine P, Cull, Vanessa S

“…Delivery of type I interferon (IFN) subtypes by intramuscular inoculation of mice with a recombinant mammalian expression vector encoding IFN stimulates the…”
Get more information

Type I IFN- gene therapy suppresses cardiac CD8 T-cell infiltration during autoimmune myocarditis by Bartlett, Emmalene J, Lenzo, Jason C, Sivamoorthy, Soruba, Mansfield, Josephine P, Cull, Vanessa S, James, Cassandra M

“…SummaryGene therapy using DNA encoding type I IFN subtypes IFNA6, IFNA9 and IFNB suppresses murine cytomegalovirus (MCMV)-myocarditis, a predominantly…”
Get full text

Amiloride Suppresses Erythropoietin-Induced Proliferation and MAP Kinase, but Potentiates Differentiation of J2E Cells by Callus, Bernard, Tilbrook, Peta A., Busfield, Samatha J., Cull, Vanessa S., Bittorf, Thomas, Klinken, S.Peter

“…The J2E erythroid cell line proliferates and differentiates in response to erythropoietin (epo). Here we demonstrate that the diuretic amiloride can suppress…”
Get full text